Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LSD Therapy
Recent news which mentions LSD Therapy
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers
MNMD
NEWS
Tags
Management
Legal
Psychedelic/Assisted Therapies
From
Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
March 08, 2024
Tickers
MNMD
NEWS
Tags
News
Market News
Cannabis
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
News
Breakthrough Therapy Drug
LSD Therapy
From
Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
Tags
Market News
Cannabis
LSD Therapy
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
Psychedelics
Benzinga
Generalized Anxiety Disorder
From
Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
August 23, 2023
Tags
News
LSD Therapy
Federico Fellini
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
FDA
Psychedelic/Assisted Therapies
PHRRF
From
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers
CMPS
MNMD
NUMIF
Tags
MNMD
Cedar Clinical Research
Psychedelics
From
Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
Tickers
MNMD
Tags
FCM MM Holdings
Psychedelic/Assisted Therapies
Proxy fight
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Penny Stocks
News
Markets
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
Psychedelic/Assisted Therapies
Benzinga
Psychedelics
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
News
Guidance
Penny Stocks
From
Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
January 13, 2023
Tags
News
Benzinga
Psychedelics
From
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
Tickers
AWKNF
CMND
CMPS
PSIL
Tags
Psychedelic Research
Benzinga
Psychedelics
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
clinical trials
Penny Stocks
Earnings
From
Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Tickers
BLRZF
Tags
Markets
Market News
Cannabis
From
Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
September 27, 2022
Tickers
BETRF
Tags
Psychedelics
Penny Stocks
Benzinga
From
Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
September 08, 2022
Tickers
MNMD
Tags
LSD Therapy
Markets
anxiety disorders
From
Benzinga
Connecting To Nature Through Psychedelics
April 17, 2022
Tickers
TECH
Tags
Tech
Nature
contributors
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright